2021 CMSC Annual Meeting

Tag: (2)Janssen Research & Development

Poster-Quality of Life and Outcomes

Assessing the Impact of Disease Activity and Fatigue Symptom on Work Productivity and Activity Impairment in Patients with Relapsing Multiple Sclerosis

Background: Multiple Sclerosis (MS) is well known to reduce work productivity and adversely affect usual activities. Although previous...

Read More

Poster-Quality of Life and Outcomes

Differences in Expected Number of Clinical Management Events before and during Treatment with Sphingosine-1-Phosphate Receptor Modulators for Multiple Sclerosis

Background: Sphingosine-1-phosphate receptor modulators (S1Ps), a class of oral disease-modifying therapies (DMTs) for multiple sclerosis...

Read More